Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progressi... Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progression of various cancers. The company has a lead product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. It is advancing KO-947, a small molecule inhibitor of extracellular-signal-regulated kinase (ERK), as a treatment for patients with pancreatic cancer, colorectal cancer, non-small cell lung cancer (NSCLC) and melanoma. Geographically operation of the group is carried through the United States. Show more
– Ziftomenib induces insulin production, improves insulin sensitivity and reduces insulin resistance in preclinical model of type 2 diabetes – – Kura advancing multiple, next-generation menin...
SAN DIEGO, June 07, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision...
SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.09 | 0.441609421001 | 20.38 | 21.85 | 20.01 | 946615 | 20.85337833 | CS |
4 | -0.45 | -2.15105162524 | 20.92 | 22.675 | 19.41 | 690205 | 21.01755244 | CS |
12 | 0.38 | 1.89148830264 | 20.09 | 23.1 | 16.79 | 713625 | 20.30921647 | CS |
26 | 6.22 | 43.649122807 | 14.25 | 24.17 | 13.29 | 1086464 | 19.86121834 | CS |
52 | 10.17 | 98.7378640777 | 10.3 | 24.17 | 7.41 | 942231 | 15.68010175 | CS |
156 | -1.73 | -7.79279279279 | 22.2 | 24.17 | 7.41 | 831768 | 14.98539347 | CS |
260 | 0.55 | 2.76104417671 | 19.92 | 42.82 | 6.34 | 718480 | 17.7405753 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.